Related Experiment Video
Updated: Mar 29, 2026

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
Published on: April 7, 2015
Clinical presentation of infective endocarditis caused by different groups of non-beta haemolytic streptococci
B Nilson1,2, L Olaison3,4, M Rasmussen5
1Clinical Microbiology, Labmedicin, Region Skåne, Lund, Sweden.
Abstract:
Streptococci are common causes of infective endocarditis (IE) and matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) has provided a practical tool for their species determination. We aimed to investigate if particular groups of non-beta heamolytic streptococci were associated with IE or to specific presentations thereof. The Swedish Registry of Infective Endocarditis was used to identify cases of IE caused by streptococci and a local database to identify cases of streptococcal bacteremia. The bacteria were grouped using MALDI-TOF MS and the clinical characteristics of IE caused by different groups were compared. We identified a group of 201 streptococcal IE isolates: 18 isolates belonged to the anginosus, 19 to the bovis, 140 to the mitis, 17 to the mutans, and seven to the salivarius groups. The mitis and mutans groups were significantly more common and the anginosus group less common among IE cases as compared to all cause bacteremia. Patients infected with the bovis group isolates were older, had more cardiac devices, and had more commonly prosthetic valve IE compared to IE caused by streptococci of the other groups. Twenty-one percent of patients needed surgery, and in-hospital mortality was 8% with no significant differences between the groups. Grouping of non-beta haemolytic streptococci using MALDI-TOF MS can provide a basis for decision-making in streptococcal bacteremia. IE caused by bovis group isolates have clinical characteristics distinguishing them from IE caused by other groups of Streptococcus.
Insights
Matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) aids in identifying streptococcal infective endocarditis (IE) causes. The bovis group of Streptococcus shows distinct clinical features in IE patients compared to other groups.
Area of Science:
- Microbiology
- Infectious Diseases
- Clinical Diagnostics
Background:
- Streptococci are frequent causes of infective endocarditis (IE).
- Matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) is a key tool for bacterial species identification.
- Non-beta-hemolytic streptococci require further investigation regarding their specific roles in IE.
Purpose of the Study:
- To determine if specific non-beta-hemolytic streptococci groups are associated with infective endocarditis (IE).
- To compare clinical presentations of IE caused by different streptococcal groups.
Main Methods:
- Utilized the Swedish Registry of Infective Endocarditis and a local bacteremia database.
- Employed MALDI-TOF MS for grouping 201 streptococcal IE isolates into anginosus, bovis, mitis, mutans, and salivarius groups.
- Compared clinical characteristics of IE cases based on streptococcal groupings.
Main Results:
- Mitis and mutans groups were more prevalent in IE cases than in general bacteremia; anginosus group was less common.
- Streptococcus bovis group infections were associated with older patients, more cardiac devices, and prosthetic valve IE.
- No significant differences in surgical necessity (21%) or in-hospital mortality (8%) were observed between groups.
Conclusions:
- MALDI-TOF MS grouping of non-beta-hemolytic streptococci provides valuable insights for managing streptococcal bacteremia.
- Infective endocarditis caused by the bovis group exhibits distinct clinical characteristics, aiding in differential diagnosis and patient management.
Related Concept Videos
Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis I: Introduction
Endocarditis IV: Nursing Management
Myocarditis II: Clinical Features and Diagnostic Tests
Endocarditis III: Medical Management
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
